Rhythm Pharmaceuticals (RYTM) Non-Current Deferred Tax Liability (2021)
Rhythm Pharmaceuticals (RYTM) posted quarterly Non-Current Deferred Tax Liability of $8.0 million for Q3 2021, down 52.96% quarter-over-quarter from $17.0 million in Q2 2021.
Rhythm Pharmaceuticals (RYTM) Non-Current Deferred Tax Liability (2021) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Non-Current Deferred Tax Liability for 1 consecutive years, with $8.0 million the latest figure, recorded in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 7.99 Mn |
| Sep 30, 2021 | 7.99 Mn |
| Jun 30, 2021 | 16.98 Mn |
| Jun 30, 2021 | 16.98 Mn |
| Mar 31, 2021 | 22.01 Mn |
| Mar 31, 2021 | 22.01 Mn |